{"id":"https://openalex.org/W2000692862","doi":"https://doi.org/10.1002/pds.1804","title":"Case series of liver failure associated with rosiglitazone and pioglitazone","display_name":"Case series of liver failure associated with rosiglitazone and pioglitazone","alternate_titles":[],"publication_year":2009,"publication_date":"2009-07-22","ids":{"openalex":"https://openalex.org/W2000692862","doi":"https://doi.org/10.1002/pds.1804","mag":"2000692862","pmid":"https://pubmed.ncbi.nlm.nih.gov/19623674"},"language":"en","primary_location":{"id":"doi:10.1002/pds.1804","doi":"https://doi.org/10.1002/pds.1804","is_oa":false,"landing_page_url":"https://doi.org/10.1002/pds.1804","pdf_url":null,"source":{"id":"https://openalex.org/S140231191","display_name":"Pharmacoepidemiology and Drug Safety","issn_l":"1053-8569","issn":["1053-8569","1099-1557"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacoepidemiology and Drug Safety","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2000692862"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5060145270","display_name":"James S. Floyd","orcid":"https://orcid.org/0000-0002-0365-9041","observed_orcids":["https://orcid.org/0000-0002-0365-9041"]},"institutions":[{"id":"https://openalex.org/I4210151745","display_name":"Public Citizen","ror":"https://ror.org/04ygg1h35","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210151745"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"James S. Floyd","raw_affiliation_strings":["Public Citizen, Health Research Group, 1600 20th Street NW, Washington, DC 20009, USA. jfloyd@citizen.org","Public Citizen, Health Research Group, Washington, DC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Public Citizen, Health Research Group, 1600 20th Street NW, Washington, DC 20009, USA. jfloyd@citizen.org","institution_ids":["https://openalex.org/I4210151745"]},{"raw_affiliation_string":"Public Citizen, Health Research Group, Washington, DC, USA","institution_ids":["https://openalex.org/I4210151745"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090131296","display_name":"Elizabeth K. Barbehenn","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210151745","display_name":"Public Citizen","ror":"https://ror.org/04ygg1h35","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210151745"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Elizabeth Barbehenn","raw_affiliation_strings":["Public Citizen, Health Research Group, Washington, DC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Public Citizen, Health Research Group, Washington, DC, USA","institution_ids":["https://openalex.org/I4210151745"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031523024","display_name":"Peter G. Lurie","orcid":"https://orcid.org/0000-0001-7867-4951","observed_orcids":["https://orcid.org/0000-0001-7867-4951"]},"institutions":[{"id":"https://openalex.org/I4210151745","display_name":"Public Citizen","ror":"https://ror.org/04ygg1h35","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210151745"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Peter Lurie","raw_affiliation_strings":["Public Citizen, Health Research Group, Washington, DC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Public Citizen, Health Research Group, Washington, DC, USA","institution_ids":["https://openalex.org/I4210151745"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5111778825","display_name":"Sidney M. Wolfe","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210151745","display_name":"Public Citizen","ror":"https://ror.org/04ygg1h35","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210151745"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Sidney M. Wolfe","raw_affiliation_strings":["Public Citizen, Health Research Group, Washington, DC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Public Citizen, Health Research Group, Washington, DC, USA","institution_ids":["https://openalex.org/I4210151745"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5060145270"],"corresponding_institution_ids":["https://openalex.org/I4210151745"],"apc_list":{"value":4650,"currency":"USD","value_usd":4650},"apc_paid":null,"fwci":3.0302,"has_fulltext":false,"cited_by_count":67,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.89930122,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":98},"biblio":{"volume":"18","issue":"12","first_page":"1238","last_page":"1243"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11465","display_name":"Drug-Induced Hepatotoxicity and Protection","score":0.9717000126838684,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11465","display_name":"Drug-Induced Hepatotoxicity and Protection","score":0.9717000126838684,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.023000000044703484,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13467","display_name":"Drug-Induced Ocular Toxicity","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/rosiglitazone","display_name":"rosiglitazone","score":0.9710000157356262},{"id":"https://openalex.org/keywords/pioglitazone","display_name":"pioglitazone","score":1.0},{"id":"https://openalex.org/keywords/thiazolidinediones","display_name":"thiazolidinediones","score":0.9869999885559082},{"id":"https://openalex.org/keywords/drug-induced-liver-failure","display_name":"drug-induced liver failure","score":0.902999997138977},{"id":"https://openalex.org/keywords/hepatotoxicity","display_name":"hepatotoxicity","score":0.9769999980926514},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.7710000276565552},{"id":"https://openalex.org/keywords/fda-adverse-event-reporting-system","display_name":"FDA Adverse Event Reporting System","score":0.8500000238418579},{"id":"https://openalex.org/keywords/case-fatality-rate","display_name":"case fatality rate","score":0.7649999856948853},{"id":"https://openalex.org/keywords/number-needed-to-harm","display_name":"number needed to harm","score":0.9440000057220459},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.44999998807907104}],"concepts":[{"id":"https://openalex.org/C2778384471","wikidata":"https://www.wikidata.org/wiki/Q417765","display_name":"Pioglitazone","level":4,"score":0.983041524887085},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9294322729110718},{"id":"https://openalex.org/C2780152017","wikidata":"https://www.wikidata.org/wiki/Q424771","display_name":"Rosiglitazone","level":3,"score":0.857421875},{"id":"https://openalex.org/C2779609443","wikidata":"https://www.wikidata.org/wiki/Q1368191","display_name":"Liver transplantation","level":3,"score":0.5863049626350403},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5858614444732666},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5141056180000305},{"id":"https://openalex.org/C2776923340","wikidata":"https://www.wikidata.org/wiki/Q1393556","display_name":"Thiazolidinedione","level":4,"score":0.5029441714286804},{"id":"https://openalex.org/C2994427840","wikidata":"https://www.wikidata.org/wiki/Q970208","display_name":"Liver failure","level":2,"score":0.4702892303466797},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.2166576087474823},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.2144186794757843},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.16139662265777588},{"id":"https://openalex.org/C2911091166","wikidata":"https://www.wikidata.org/wiki/Q106419912","display_name":"Transplantation","level":2,"score":0.13769260048866272},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.04877227544784546}],"mesh":[{"descriptor_ui":"D000077154","descriptor_name":"Rosiglitazone","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000077205","descriptor_name":"Pioglitazone","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012307","descriptor_name":"Risk Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016208","descriptor_name":"Databases, Factual","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016907","descriptor_name":"Adverse Drug Reaction Reporting Systems","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D017093","descriptor_name":"Liver Failure","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D045162","descriptor_name":"Thiazolidinediones","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D045162","descriptor_name":"Thiazolidinediones","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D056486","descriptor_name":"Chemical and Drug Induced Liver Injury","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1002/pds.1804","doi":"https://doi.org/10.1002/pds.1804","is_oa":false,"landing_page_url":"https://doi.org/10.1002/pds.1804","pdf_url":null,"source":{"id":"https://openalex.org/S140231191","display_name":"Pharmacoepidemiology and Drug Safety","issn_l":"1053-8569","issn":["1053-8569","1099-1557"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacoepidemiology and Drug Safety","raw_type":"journal-article"},{"id":"pmid:19623674","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19623674","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacoepidemiology and drug safety","raw_type":"Case Reports"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":30,"referenced_works":["https://openalex.org/W120815510","https://openalex.org/W1486420949","https://openalex.org/W1556584205","https://openalex.org/W1966656294","https://openalex.org/W1975622853","https://openalex.org/W1999571240","https://openalex.org/W2007321808","https://openalex.org/W2013839061","https://openalex.org/W2017972660","https://openalex.org/W2026759021","https://openalex.org/W2029737946","https://openalex.org/W2030288242","https://openalex.org/W2030580012","https://openalex.org/W2039968901","https://openalex.org/W2052245273","https://openalex.org/W2052659545","https://openalex.org/W2053595725","https://openalex.org/W2059156599","https://openalex.org/W2061950292","https://openalex.org/W2070538200","https://openalex.org/W2094798623","https://openalex.org/W2127066946","https://openalex.org/W2128080366","https://openalex.org/W2134956122","https://openalex.org/W2144435035","https://openalex.org/W2159145664","https://openalex.org/W2165509099","https://openalex.org/W2323519181","https://openalex.org/W4230040438","https://openalex.org/W4240449862"],"related_works":["https://openalex.org/W2019596183","https://openalex.org/W2915742425","https://openalex.org/W1966656294","https://openalex.org/W2127066946","https://openalex.org/W2013177685","https://openalex.org/W2080858771","https://openalex.org/W1999571240","https://openalex.org/W2128080366","https://openalex.org/W1566733175","https://openalex.org/W2159145664"],"abstract_inverted_index":{"PURPOSE:":[0],"The":[1,144,170],"thiazolidinedione":[2],"drugs":[3,236],"rosiglitazone":[4,35,67,140,204,225],"and":[5,36,40,42,128,141,152,176,205],"pioglitazone":[6,37,69,227],"are":[7],"not":[8],"widely":[9],"known":[10],"to":[11,23,53,59,162,188,229],"be":[12],"hepatotoxic.":[13],"We":[14],"evaluated":[15],"the":[16,25,54,100,185,216,232],"FDA":[17,55],"Adverse":[18,48],"Event":[19],"Reporting":[20],"System":[21],"(AERS)":[22],"determine":[24],"number":[26,101,186],"of":[27,30,102,105,111,135,147,154,194,201,209,220],"reported":[28,103,228],"cases":[29,104,120,134,155],"liver":[31,73,79,84,106,136,163,195,221],"failure":[32,64,107,137,164,196,222],"associated":[33,65,138,223],"with":[34,66,139,142,224],"between":[38,133],"1997":[39,58],"2006,":[41],"described":[43],"their":[44],"clinical":[45],"characteristics.":[46],"METHODS:":[47],"event":[49],"reports":[50],"spontaneously":[51,180],"submitted":[52],"AERS":[56],"from":[57],"2006":[60],"were":[61,95,131,156],"examined.":[62],"Liver":[63],"or":[68,87,226],"was":[70,113,149,173,197],"defined":[71,158],"as":[72,159],"injury":[74],"accompanied":[75],"by":[76],"hepatic":[77],"encephalopathy,":[78],"transplantation,":[80],"placement":[81],"on":[82],"a":[83],"transplant":[85],"list,":[86],"death":[88],"in":[89,165],"which":[90],"all":[91],"other":[92],"likely":[93],"etiologies":[94],"excluded.":[96],"Using":[97],"prescribing":[98],"data,":[99],"per":[108],"million":[109],"patient-years":[110,200,208],"exposure":[112,202,210],"calculated":[114],"for":[115,183,191,203,211],"each":[116,192],"drug.":[117],"RESULTS:":[118],"Twenty-one":[119],"met":[121],"our":[122],"case":[123,193,218],"definition.":[124],"Clinical":[125],"characteristics,":[126],"outcomes,":[127],"pathologic":[129],"data":[130],"similar":[132],"pioglitazone.":[143,212],"median":[145],"duration":[146],"therapy":[148],"9":[150],"weeks":[151],"85%":[153],"acute,":[157],"symptom":[160],"onset":[161],"less":[166],"than":[167],"26":[168],"weeks.":[169],"case-fatality":[171],"rate":[172],"81%":[174],"(17/21),":[175],"only":[177],"14%":[178],"(3/21)":[179],"recovered.":[181],"Accounting":[182],"underreporting,":[184],"needed":[187],"harm":[189],"(NNH)":[190],"44":[198],"000":[199,207],"52":[206],"CONCLUSIONS:":[213],"This":[214],"is":[215],"largest":[217],"series":[219],"date,":[230],"strengthening":[231],"evidence":[233],"that":[234],"these":[235],"can":[237],"cause":[238],"severe":[239],"hepatotoxicity.":[240]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2000692862","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":5},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":6},{"year":2014,"cited_by_count":5},{"year":2013,"cited_by_count":5},{"year":2012,"cited_by_count":5}],"updated_date":"2026-11-18T13:11:19.462570","created_date":"2016-06-24T00:00:00"}
